As of April 2024 Marinus Pharmaceuticals has a market cap of $79.1 Million. This makes Marinus Pharmaceuticals the world's 7526th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $79.1 M | -86.67% |
2023 | $0.59 B | 200.39% |
2022 | $0.19 B | -54.79% |
2021 | $0.43 B | -2.12% |
2020 | $0.44 B | 138.87% |
2019 | $0.18 B | 23.96% |
2018 | $0.15 B | -54.41% |
2017 | $0.33 B | 1561.37% |
2016 | $19.9 M | -86.57% |
2015 | $0.14 B | 0.06% |
2014 | $0.14 B |
On Apr 24th, 2024 the market cap of Marinus Pharmaceuticals was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Supernus Pharmaceuticals
SUPN | $1.65 B | 1,993.89% | ๐บ๐ธ USA |
Endo International
ENDPQ | $0.14 M | -99.82% | ๐ฎ๐ช Ireland |
AcelRx Pharmaceuticals
ACRX | $14.57 M | -81.57% | ๐บ๐ธ USA |
Eagle Pharmaceuticals
EGRX | $58.95 M | -25.46% | ๐บ๐ธ USA |